Top Industry Leaders in the Brain Ischemia Market
Latest Brain Ischemia Companies Updates:
Penumbra, Announced launch of the Indigo System, a next-generation aspiration catheter for removing blood clots in ischemic stroke (Dec 2023).
Stryker Corporation (US) Received FDA approval for its MobiLink VRT Neuro Interventional System, enabling remote guidance for stroke interventions (Nov 2023).
Actelion Pharmaceuticals Ltd. (Switzerland) Presented positive Phase 2 data for its investigational drug macitentan in mild cognitive impairment associated with vascular disease (Jan 2024).
iSchemaView (Canada) Expanded availability of its RAPID platform for rapid stroke analysis to 52 hospitals across Canada (Jan 2024).
Boehringer Ingelheim GmbH (Germany) Initiated Phase 3 trial for its candidate drug BI 655825 targeting neuronal injury after ischemic stroke (Oct 2023).
List of Brain Ischemia Key companies in the market:
- Taxus Cardium (US)
- Edwards Lifesciences Corporation (US)
- Boston Scientific Corporation (US)
- Merck KGaA (Germany)
- Medtronic (Ireland), Cook Medical (US)
- Novartis AG (Switzerland)
- Boehringer Ingelheim International GmbH (Germany)
- Abbott (US)
- Dickinson and Company (US)
- Johnson & Johnson Services Inc. (US)